Kumiya Sugiyama
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 17, 2024
Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung Disease.Naotatsu Otsuji, Kumiya Sugiyama, Takayoshi Owada
|Apr 04, 2022
The challenge of differentiating tuberculous meningitis from bacterial meningitis.Momoko Kurihara, Tomonori Kuroki, Yushi Nomura
|Mar 26, 2022
Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination.Ryousuke Koike, Michiru Sawahata, Yosikazu Nakamura
|Dec 28, 2021
Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months.Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura
|Sep 28, 2021
Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine.Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura
|Jun 01, 2018
Risk factors for disseminated intravascular coagulation in patients with lung cancer.Kentaro Nakano, Kumiya Sugiyama, Hideyuki Satoh
Pageof 2
